BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15159697)

  • 1. Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia.
    Kaneda Y; Kawamura I; Fujii A; Ohmori T
    Neuro Endocrinol Lett; 2004; 25(1-2):135-40. PubMed ID: 15159697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of quetiapine on gonadal axis hormones in male patients with schizophrenia: a preliminary, open study.
    Kaneda Y; Ohmori T
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):875-8. PubMed ID: 12921922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
    Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
    J Clin Psychiatry; 2004 Nov; 65(11):1525-30. PubMed ID: 15554767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between plasma homovanillic acid levels and the response to atypical antipsychotics in male patients with schizophrenia.
    Kaneda Y; Kawamura I; Ohmori T
    Clin Neuropharmacol; 2005; 28(6):262-4. PubMed ID: 16340379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbation.
    Kaneda Y; Ohmori T
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):247-52. PubMed ID: 12974991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aging on the improvement of subjective sleep quality by atypical antipsychotic drugs in patients with schizophrenia: comparison of middle-aged and older adults.
    Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
    Am J Geriatr Psychiatry; 2005 May; 13(5):377-84. PubMed ID: 15879586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine.
    Voruganti LP; Awad AG; Parker G; Forrest C; Usmani Y; Fernando ML; Senthilal S
    Schizophr Res; 2007 Nov; 96(1-3):146-55. PubMed ID: 17728106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.
    Konarzewska B; Wołczyński S; Szulc A; Galińska B; Popławska R; Waszkiewicz N
    Psychoneuroendocrinology; 2009 Jan; 34(1):129-39. PubMed ID: 18838228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of prolactin elevation with antipsychotic medications on subjective quality of life in patients with schizophrenia.
    Kaneda Y
    Clin Neuropharmacol; 2003; 26(4):182-4. PubMed ID: 12897637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of risperidone on gonadal axis hormones in schizophrenia.
    Kaneda Y
    Ann Pharmacother; 2001 Dec; 35(12):1523-7. PubMed ID: 11793612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.
    Voruganti L; Cortese L; Owyeumi L; Kotteda V; Cernovsky Z; Zirul S; Awad A
    Schizophr Res; 2002 Oct; 57(2-3):201-8. PubMed ID: 12223251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.
    Cohrs S; Röher C; Jordan W; Meier A; Huether G; Wuttke W; Rüther E; Rodenbeck A
    Psychopharmacology (Berl); 2006 Mar; 185(1):11-8. PubMed ID: 16432682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
    J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
    Swartz MS; Perkins DO; Stroup TS; Davis SM; Capuano G; Rosenheck RA; Reimherr F; McGee MF; Keefe RS; McEvoy JP; Hsiao JK; Lieberman JA;
    Am J Psychiatry; 2007 Mar; 164(3):428-36. PubMed ID: 17329467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of antipsychotic drugs on life quality of schizophrenic patients: one year follow-up study].
    Fang M; Li L; Zhao J; Chen H; Ye M; Guo X; Lu Z; Sun X; Wang C; Xie S; Hu B; Guo T; Ma C; Wang B; Lü L; Liu N; Deng H; Chen Q; Shang X; Gong F; Zhang X; He X; Zhou J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 34(9):850-5. PubMed ID: 19779255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
    Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
    J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
    Wetzel H; Szegedi A; Hain C; Wiesner J; Schlegel S; Benkert O
    Psychopharmacology (Berl); 1995 May; 119(2):231-8. PubMed ID: 7659771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perospirone.
    Onrust SV; McClellan K
    CNS Drugs; 2001; 15(4):329-37; discussion 338. PubMed ID: 11463136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.
    Loebel A; Cucchiaro J; Sarma K; Xu L; Hsu C; Kalali AH; Pikalov A; Potkin SG
    Schizophr Res; 2013 Apr; 145(1-3):101-9. PubMed ID: 23415311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.